risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some mibc
Published 1 year ago • 66 plays • Length 5:13Download video MP4
Download video MP3
Similar videos
-
11:44
retain: risk-enabled therapy after neoadjuvant chemo for mibc
-
3:34
neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in os
-
2:26
niagara: perioperative durvalumab with neoadjuvant chemotherapy in mibc
-
2:05
adding nivolumab to neoadjuvant chemo improves response rate for high risk er her2− breast cancer
-
1:45
role of neoadjuvant chemotherapy in patients undergoing bladder-sparing treatments
-
2:41
surgical experience after neoadjuvant chemo-immunotherapy
-
2:25
reducing risk in residual breast cancer
-
1:39
sano-trial: neoadjuvant chemo-rt followed by surgery vs. active surveillance for oesophageal cancer
-
2:40
sano-trial: neoadjuvant chemoradiotherapy vs. active surveillance in esophageal cancer
-
1:59
effectiveness of icis in the neoadjuvant and post-neoadjuvant breast cancer setting
-
0:53
what is neoadjuvant therapy?
-
10:05
exploring neoadjuvant therapy for breast cancer: what you need to know
-
0:43
understanding the benefits and risks of chemotherapy for breast cancer patients 🎗️💊
-
8:22
the immune landscape of residual tnbc after neoadjuvant chemotherapy
-
3:08
where does neoadjuvant chemotherapy in advanced ovarian cancer fit in clinical practice?
-
2:40
chemotherapy
-
2:04
a phase ii trial investigating neoadjuvant abiraterone and cabazitaxel in high-risk prostate cancer
-
2:12
the role of curative neoadjuvant treatment in certain cancer types
-
16:42
neoadjuvant therapy for mibc in the genomic era